UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Science translational medicine, ISSN 1946-6234, 11/2018, Volume 10, Issue 466, p. eaat4921
b_open_article_in_toll_access_journal | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Circulating Tumor DNA - analysis | Circulating Tumor DNA - chemistry | Animals | Humans | DNA Copy Number Variations - genetics | Mice | Circulating Tumor DNA - blood | Genome, Human | Mutation - genetics | Machine Learning | Whole Genome Sequencing | Size distribution | Genomic analysis | Glioma | Prediction models | Copy number | Pancreatic cancer | Genomes | Deoxyribonucleic acid--DNA | Index Medicus
Journal Article
Talanta (Oxford), ISSN 0039-9140, 02/2021, p. 122220
Journal Article
Journal of thoracic oncology, ISSN 1556-0864, 09/2017, Volume 12, Issue 9, pp. 1376 - 1387
Heterogeneity | Non–small cell lung cancer | Discordance of mutation | Epidermal growth factor receptor mutation | Circulating tumor DNA | Respiratory System | Oncology | Life Sciences & Biomedicine | Science & Technology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Humans | ErbB Receptors - genetics | Lung Neoplasms - pathology | Male | DNA, Neoplasm - blood | Carcinoma, Non-Small-Cell Lung - blood | Female | Aged | Lung Neoplasms - blood | DNA, Neoplasm - genetics | Mutation | Index Medicus
Journal Article
Molecular oncology, ISSN 1574-7891, 04/2015, Volume 9, Issue 4, pp. 783 - 790
Liquid biopsy | Next-generation sequencing | SHIVA trial | Multiple tumor types | Circulating tumor DNA | Life Sciences & Biomedicine | Oncology | Science & Technology | Neoplasms - metabolism | Gene Frequency - genetics | Neoplastic Cells, Circulating - pathology | DNA, Neoplasm - metabolism | Humans | Middle Aged | Neoplastic Cells, Circulating - metabolism | Genotyping Techniques | Mutation - genetics | Neoplasm Metastasis | DNA, Neoplasm - blood | Neoplasms - genetics | Biopsy | Aged, 80 and over | Female | Aged | Neoplasms - pathology | Precision Medicine | Oncology, Experimental | Genes | Clinical trials | Metastasis | Research | Homeopathy | Materia medica and therapeutics | Analysis | DNA | Therapeutics | Genetic research | Drug therapy | Cancer | Plasma | Lymphatic system | Laboratories | Invasiveness | Liver | Feasibility studies | Histology | Thyroid gland | Patients | Cancer therapies | Metastases | Genotyping | Precision medicine | Mutation | Deoxyribonucleic acid--DNA | Index Medicus | s
Journal Article
European urology, ISSN 0302-2838, 2017, Volume 72, Issue 1, pp. 34 - 42
Urology | Castration-resistant prostate cancer | Abiraterone | Cell-free DNA | Liquid biopsy | Enzalutamide | BRCA2 | DNA repair | Circulating tumor DNA | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Liquid Biopsy | Circulating Tumor DNA - genetics | Humans | Middle Aged | Male | Loss of Heterozygosity | Prostatic Neoplasms, Castration-Resistant - genetics | Prostatic Neoplasms, Castration-Resistant - pathology | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Metastasis | Time Factors | DNA Mutational Analysis | Antineoplastic Agents, Hormonal - therapeutic use | Germ-Line Mutation | Kallikreins - blood | Genetic Predisposition to Disease | Prostatic Neoplasms, Castration-Resistant - blood | Kaplan-Meier Estimate | Treatment Outcome | Prostatic Neoplasms, Castration-Resistant - drug therapy | Disease Progression | Prostate-Specific Antigen - blood | Phenotype | DNA Repair | Androgen Antagonists - therapeutic use | Aged | Biomarkers, Tumor - genetics | Circulating Tumor DNA - blood | Androgen Antagonists - adverse effects | Biotechnology | Gene mutations | Patient outcomes | DNA | Genetic aspects | Metastasis | Drug therapy | Prostate cancer | Cancer | Antigens | Analysis | Genetic research | Index Medicus
Journal Article
JAMA oncology, ISSN 2374-2437, 09/2020, Volume 6, Issue 9, pp. 1410 - 1415
Life Sciences & Biomedicine | Oncology | Science & Technology | Neoplastic Cells, Circulating - drug effects | Circulating Tumor DNA - genetics | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Circulating Tumor DNA - drug effects | Triple Negative Breast Neoplasms - drug therapy | Neoplasm Recurrence, Local - pathology | Young Adult | Disease-Free Survival | Triple Negative Breast Neoplasms - genetics | Adolescent | Triple Negative Breast Neoplasms - pathology | Adult | Female | Neoadjuvant Therapy | Neoplasm Recurrence, Local - genetics | Neoplasm Staging
Journal Article
Science translational medicine, ISSN 1946-6242, 2017, Volume 9, Issue 403, p. eaan2415
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Early Detection of Cancer - methods | Genes, Neoplasm | Humans | Blood Cells - metabolism | Treatment Outcome | Neoplasms - diagnosis | Mutation - genetics | Sequence Analysis, DNA | Case-Control Studies | Disease Progression | Preoperative Care | Circulating Tumor DNA - metabolism | Neoplasms - blood | Neoplasms - genetics | Cell-Free Nucleic Acids - blood | Female | Circulating Tumor DNA - blood | Neoplasm Staging | Neoplasms - pathology | Index Medicus
Journal Article
Science translational medicine, ISSN 1946-6234, 07/2016, Volume 8, Issue 346, pp. 346ra92 - 346ra92
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Circulating Tumor DNA - analysis | Colonic Neoplasms - genetics | Prospective Studies | Circulating Tumor DNA - genetics | Neoplasm, Residual - surgery | Humans | Proportional Hazards Models | Neoplasm, Residual - blood | Neoplasm, Residual - genetics | Colonic Neoplasms - surgery | Disease-Free Survival | Colonic Neoplasms - blood | Neoplasm Recurrence, Local - genetics | Neoplasm Staging | Neoplasm Recurrence, Local - blood | Index Medicus
Journal Article
Annals of oncology, ISSN 0923-7534, 10/2014, Volume 25, Issue 10, pp. 1959 - 1965
breast cancer | targeted gene sequencing | liquid biopsy | circulating tumor DNA | Liquid biopsy | Targeted gene sequencing | Breast cancer | Circulating tumor DNA | Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Pharmacology. Drug treatments | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Tumors | PTEN Phosphohydrolase - genetics | Humans | Middle Aged | DNA, Neoplasm - isolation & purification | Isocitrate Dehydrogenase - genetics | Proto-Oncogene Proteins c-akt - genetics | Tumor Suppressor Protein p53 - genetics | Phosphatidylinositol 3-Kinases - genetics | Neoplasm Metastasis | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | DNA, Neoplasm - blood | Biopsy | DNA Mutational Analysis | Neoplastic Cells, Circulating | Breast Neoplasms - blood | Adult | Female | High-Throughput Nucleotide Sequencing | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 18, pp. 1754 - 1765
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Circulating Tumor DNA - analysis | Neoplasms - therapy | Neoplasms - genetics | Standard of Care | Liquid Biopsy - methods | Humans | DNA, Neoplasm - analysis | Neoplasms - diagnosis | Circulating Tumor DNA - blood | Mutation | Care and treatment | Cancer patients | Usage | Genetic aspects | Nucleotide sequencing | Health aspects | Cancer | DNA sequencing | Fluids | DNA methylation | Patients | Cancer therapies | Deoxyribonucleic acid--DNA | Tumors | Index Medicus | Abridged Index Medicus
Journal Article